Purchase Order 36C26222P1753

Award Date 8/10/22
Potential Completion Date 8/10/23
Potential Value $1.3M
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Castleton, IN 46256, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $169,400.44 firm fixed-price purchase order contract awarded to Roche Diagnostics Corporation, a manufacturer of in vitro diagnostics, reagents, and laboratory instruments. The contract is with the Department of Veterans Affairs' Veterans Integrated Service Network 22 and does not have a set-aside designation. Through this award, Roche Diagnostics will provide reagents to support medical testing and laboratory operations at VA facilities. Roche Diagnostics has a history of providing...
This firm-fixed-price purchase order was awarded to Roche Diagnostics Corporation by the Department of Veterans Affairs' Veterans Integrated Service Network 22 for the provision of reagents. The $1,212,192.13 contract has a completion date of January 21, 2022 and was not set aside for any specific business category. Roche Diagnostics, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services, has held numerous federal contracts...
This is a firm fixed-price purchase order contract awarded by the Department of Veterans Affairs (VA) to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The $2,164,547.19 ceiling contract is for the supply of REAGENTS with an ultimate completion date of August 10, 2024. The contract does not have a set-aside designation. Roche Diagnostics holds several Indefinite Delivery Contracts...
This firm fixed-price purchase order contract was awarded by the Department of Veterans Affairs (VA) to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, for the provision of reagents and consumables. The contract has a ceiling value of $181,321.55 and a performance period ending on March 13, 2025. Roche Diagnostics is a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The contract does not have a...
This is a firm fixed-price purchase order awarded by the Veterans Integrated Service Network 2 (VISN 2), a civilian agency within the Department of Veterans Affairs (VA), to Roche Diagnostics Corporation for the procurement of VENTANA reagents and consumables. The contract has a ceiling value of $19,212.05 and an ultimate completion date of December 31, 2025. Roche Diagnostics Corporation is a leading manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and...
This is a $102,970.11 firm fixed-price purchase order awarded by the U.S. Department of Veterans Affairs (VA) to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The contract is for REAGENTS and has no set-aside designation. Roche Diagnostics has provided critical medical equipment, supplies, and services to the VA, Department of Defense, Department of Health and Human Services, and...
This federal contract award is for reagents with a ceiling value of $34,397.44. The prime contractor is Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The contract was awarded by the U.S. Department of Veterans Affairs (VA) through the Veterans Integrated Service Network 1 (VISN 1), with an ultimate completion date of August 14, 2025. Roche...
This is a $400,033 firm fixed price purchase order awarded by the Veterans Integrated Service Network 22 (VISN 22) of the U.S. Department of Veterans Affairs to Roche Diagnostics Corporation, a foreign-owned for-profit manufacturer of medical diagnostic products and equipment. The contract is for the delivery of reagents, with a period of performance through August 10, 2025. Roche Diagnostics has previously received other prime and subcontract awards from the VA, Department of Defense,...
This federal contract award to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, is for the provision of Roche reagents and supplies. The contract has a ceiling value of $179,305.59 and a period of performance through December 9, 2024. It was awarded on October 1, 2023 by the Veterans Integrated Service Network 6, a civilian agency of the Department of Veterans Affairs. The contract is a delivery order under an existing contract vehicle and is not set aside for any...
This is a $81,448.57 fixed-price purchase order awarded to Roche Diagnostics Corporation by the Department of Veterans Affairs' Veterans Integrated Service Network 9. The contract is not set aside and provides reagents, a type of medical laboratory supply, to be delivered by February 2020. Roche Diagnostics, a manufacturer and distributor of in vitro diagnostics and related products, has been awarded numerous federal contracts and subcontracts to provide medical equipment, consumables, and...

This is a firm fixed-price purchase order contract awarded by the Veterans Integrated Service Network 22, a civilian agency within the Department of Veterans Affairs, to Roche Diagnostics Corporation for the supply of reagents. The contract has a ceiling value of $1,297,713.57 and a period of performance ending on August 10, 2023. Roche Diagnostics Corporation is a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The contract does not have a set-aside designation. Roche Diagnostics has previously received other contract awards from various federal agencies, including the Department of Defense and Department of Health and Human Services, to provide critical care analyzers, reagents, test kits, and associated laboratory equipment, supplies, and services. The reagents provided under this contract will support the delivery of healthcare services to veterans, active duty military personnel, dependents, retirees, and civilian patients.

Generated 1/31/25, 9:21 AM